Anlotinib, Penpulimab and Capecitabine in Recurrent/Metastatic Nasopharyngeal Carcinoma
Clinical trial NCT05807880 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05807880
- Sponsor
- Sun Yat-sen University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-01
- Primary completion
- 2025-07-30
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.